Roivant Sciences Ltd. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-17 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.5M | 2.0M | 1.6M | 2.2M | 7.6M | 9.0M | 4.5M | 8.0M |
| Cost of Goods Sold | 320K | 700K | 111K | 154K | 205K | 259K | 234K | 213K |
| Gross Profit | 2.2M | 1.3M | 1.5M | 2.0M | 7.4M | 8.8M | 4.2M | 7.8M |
| R&D Expenses | 198.9M | 165.4M | 164.6M | 152.9M | 145.2M | 141.6M | 143.1M | 120.5M |
| Operating Expenses | 357.2M | 340.5M | 307.7M | 286.9M | 292.3M | 283.1M | 346.0M | 110.0M |
| Operating Income | -355.0M | -339.2M | -306.2M | -284.9M | -285.0M | -274.4M | -341.7M | -102.2M |
| Other Income / Gains | 809.1M | 48.8M | 147.2M | 15.7M | 81.9M | 39.9M | 117.3M | 82.6M |
| Net Income | 303.0M | -265.9M | -113.5M | -223.4M | -206.5M | 169.4M | -230.2M | 95.3M |
| EPS (Diluted) | 0.43 | -0.38 | -0.17 | -0.33 | -0.29 | 0.23 | -0.31 | 0.13 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.873 | 0.65 | 0.929 | 0.929 | 0.973 | 0.971 | 0.948 | 0.973 |
| General And Administrative Expenses | 158.3M | 175.1M | 143.1M | 134.0M | 147.1M | 141.5M | 202.9M | 99.9M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 158.3M | 175.1M | 143.1M | 134.0M | 147.1M | 141.5M | 202.9M | 99.9M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -110.4M |
| Cost And Expenses | 357.5M | 341.2M | 307.8M | 287.1M | 292.5M | 283.4M | 346.2M | 110.2M |
| Interest Income | 41.2M | 43.3M | 45.3M | 48.3M | 54.6M | 61.9M | 69.8M | 72.1M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.4M |
| Depreciation And Amortization | 638K | 691K | 921K | 1.1M | 1.4M | 2.9M | 4.8M | 4.9M |
| Ebitda | -354.4M | -338.5M | -305.3M | -283.8M | -283.5M | -271.5M | -336.9M | -207.7M |
| Ebitdaratio | -140.618 | -169.316 | -194.342 | -130.794 | -37.456 | -30.102 | -75.278 | -26.00 |
| Operating Income Ratio | -140.871 | -169.661 | -194.929 | -131.30 | -37.644 | -30.426 | -76.36 | -12.795 |
| Income Before Tax | 454.1M | -290.4M | -159.0M | -269.3M | -203.1M | -234.5M | -224.4M | -19.6M |
| Income Before Tax Ratio | 180.197 | -145.257 | -101.237 | -124.084 | -26.824 | -26.005 | -50.141 | -2.458 |
| Income Tax Expense | 98.4M | 23.3M | 7.0M | 4.6M | 49.3M | -25.6M | 12.5M | 12.0M |
| Net Income Ratio | 120.236 | -133.012 | -72.259 | -102.929 | -27.275 | 18.783 | -51.438 | 11.927 |
| Epsdiluted | 0.37 | -0.38 | -0.17 | -0.33 | -0.29 | 0.23 | -0.31 | 0.12 |
| Weighted Average Shs Out | 702.1M | 696.9M | 680.9M | 680.3M | 707.3M | 722.7M | 735.5M | 735.8M |
| Weighted Average Shs Out Dil | 812.3M | 696.9M | 680.9M | 680.3M | 707.3M | 722.7M | 735.5M | 781.6M |